Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Initial Treatment Phase	STARTED	Triple Combination Therapy	90
Initial Treatment Phase	STARTED	Combigan®	95
Initial Treatment Phase	COMPLETED	Triple Combination Therapy	76
Initial Treatment Phase	COMPLETED	Combigan®	83
Initial Treatment Phase	NOT COMPLETED	Triple Combination Therapy	14
Initial Treatment Phase	NOT COMPLETED	Combigan®	12
9-Month Masked Extension	STARTED	Triple Combination Therapy	67
9-Month Masked Extension	STARTED	Combigan®	73
9-Month Masked Extension	Not Enrolled in Masked Extension	Triple Combination Therapy	9
9-Month Masked Extension	Not Enrolled in Masked Extension	Combigan®	10
9-Month Masked Extension	COMPLETED	Triple Combination Therapy	54
9-Month Masked Extension	COMPLETED	Combigan®	62
9-Month Masked Extension	NOT COMPLETED	Triple Combination Therapy	13
9-Month Masked Extension	NOT COMPLETED	Combigan®	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01217606/flow